Kido Y, Sugiyama K, Nakao S, Kashiyama E, Suda T, Miyamoto G, Shimizu T, Shintani S, Kohri H
Nihon Yakurigaku Zasshi. 1986 Jul;88(1):47-56. doi: 10.1254/fpj.88.47.
The ameliorating effects of an enteral nutrient for liver failure (SF-1008C), which is enriched with branched-chain amino acids (BCAA) and includes few aromatic amino acids (AAA), were investigated. The blood ammonia, plasma and brain free amino acids, intracerebral amine concentrations and electroencephalogram were measured in portacaval shunted rats with 10% ammonium acetate (3 ml/kg, i.p.) (PCS) as a model of hepatic encephalopathy. The blood ammonia and plasma free amino acid concentrations in PCS rats were significantly increased in comparison to sham-operated (Sham) rats. Thus, the plasma BCAA/AAA ratio in PCS rats was appreciably reduced. Concomitant with the abnormal plasma amino acid concentrations, the brain free amino acid concentrations in PCS rats were markedly increased in comparison to the Sham rats. Moreover, the intracerebral tryptophan (Trp) and 5-hydroxyindol acetic acid (5-HIAA) concentrations were significantly increased, and the intracerebral dopamine (DA) concentration was significantly decreased in the PCS rats. The intracerebral serotonin (5-HT) and norepinephrine (NE) concentrations were, however, hardly changed. A smaller voltage for the electroencephalogram was used in the PCS rats than in the Sham rats. Abnormal plasma and brain free amino acid concentrations in PCS rats were normalized by oral administration of SF-1008C, and the low voltage electroencephalograms in the PCS rats were suppressed. On the other hand, abnormal plasma and brain free amino acid concentrations in the PCS rats were hardly normalized by oral administration of ED-AC, an elemental diet based on an amino acid composition of egg protein. These results suggest that SF-1008C affects brain free amino acids, intracerebral amine concentrations and electroencephalogram by ameliorating abnormal plasma free amino acid concentrations. Moreover, there is a highly significant correlation between the plasma BCAA/AAA ratio and the brain BCAA/AAA ratio, and this finding suggests that the plasma free amino acid patterns reflect the brain free amino acid patterns.
研究了一种富含支链氨基酸(BCAA)且芳香族氨基酸(AAA)含量极少的用于肝衰竭的肠内营养剂(SF - 1008C)的改善作用。以10%醋酸铵(3 ml/kg,腹腔注射)建立门腔分流大鼠(PCS)肝性脑病模型,测定其血氨、血浆和脑游离氨基酸、脑内胺浓度及脑电图。与假手术(Sham)大鼠相比,PCS大鼠的血氨和血浆游离氨基酸浓度显著升高。因此,PCS大鼠的血浆BCAA/AAA比值明显降低。与异常的血浆氨基酸浓度相伴,PCS大鼠的脑游离氨基酸浓度与Sham大鼠相比显著升高。此外,PCS大鼠脑内色氨酸(Trp)和5 - 羟吲哚乙酸(5 - HIAA)浓度显著升高,脑内多巴胺(DA)浓度显著降低。然而,脑内5 - 羟色胺(5 - HT)和去甲肾上腺素(NE)浓度几乎没有变化。PCS大鼠脑电图的电压比Sham大鼠的小。口服SF - 1008C可使PCS大鼠异常的血浆和脑游离氨基酸浓度恢复正常,并抑制其低电压脑电图。另一方面,口服基于蛋清蛋白氨基酸组成的要素膳ED - AC几乎不能使PCS大鼠异常的血浆和脑游离氨基酸浓度恢复正常。这些结果表明,SF - 1008C通过改善异常的血浆游离氨基酸浓度来影响脑游离氨基酸、脑内胺浓度和脑电图。此外,血浆BCAA/AAA比值与脑BCAA/AAA比值之间存在高度显著的相关性,这一发现表明血浆游离氨基酸模式反映了脑游离氨基酸模式。